Ben Izar's lab is a pioneer in combining single cell techniques, genome-editing, and systems biology to explore the cancer field’s most pressing problems.
Including BRCA1 testing with prenatal carrier screening could identify people at risk of breast, ovarian, and pancreatic cancer at a time when cancer screening could save their lives.
A study from Columbia researchers suggests that changing a single letter in the DNA code of selected genes in T cells may supercharge cell therapies against cancer.
High school students from the Herbert Irving Comprehensive Cancer Center's summer science program presented their research findings to Columbia scientists at an Oct. 17 poster session.
A new study shows that a shift from quiescent to activated liver cells sets the stage for liver cancer and suggests ways to reduce the risk of developing the cancer in people with liver disease.
Columbia’s Center for Comprehensive Wellness offers integrative treatments like acupuncture and massage to support cancer patients during their treatment with chemotherapy and radiation.
After skin cancer, prostate cancer is the most common cancer diagnosed among men in the United States, and about one in eight men will be diagnosed with the disease during their lifetime.
Jill Biden and Queen Letizia learned about the cancer center's work to transform care, improve diversity and access in clinical trials, and promote diversity and inclusion in science and medicine.
As part of the Biden Administration's Cancer Moonshot initiative, First Lady Jill Biden and Queen Letizia of Spain visited Columbia University's cancer center on Sept. 21.
The symposium will feature keynotes by Margaret Foti, chief executive at AACR, and Ned Sharpless, former director of the NCI, along with talks from leading members of the cancer center.
Columbia researchers have found that a protein released by multiple myeloma cells prevents the immune system from attacking the cancer, a finding that could lead to better treatments.